tiprankstipranks
Trending News
More News >
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Fulcrum Therapeutics (FULC) Income Statement

Compare
515 Followers

Fulcrum Therapeutics Income Statement

Last quarter (Q3 2025), Fulcrum Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Fulcrum Therapeutics's net income was $-19.59M. See Fulcrum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 80.00M$ 2.81M$ 6.34M$ 19.16M$ 8.82M
Gross Profit
$ 78.41M$ 2.81M$ -70.44M$ -50.54M$ -50.22M
Operating Expenses
$ 38.51M$ 113.47M$ 42.12M$ 30.52M$ 21.39M
Depreciation and Amortization
$ 1.59M$ 2.17M$ 2.41M$ 2.52M$ 2.38M
EBITDA
$ -18.24M$ -108.49M$ -109.72M$ -78.54M$ -69.23M
Operating Income
$ -21.90M$ -110.66M$ -112.56M$ -81.05M$ -71.61M
Other Income/Expenses
$ 12.17M$ 13.33M$ 2.69M$ 207.00K$ 792.00K
Pretax Income
$ -9.72M$ -97.33M$ -109.87M$ -80.85M$ -70.82M
Net Income
$ -9.72M$ -97.33M$ -109.87M$ -80.85M$ -70.82M
Per Share Metrics
Basic EPS
$ -0.16$ -1.59$ -2.35$ -2.22$ -2.70
Diluted EPS
$ -0.16$ -1.59$ -2.35$ -2.22$ -2.70
Weighted Average Shares Outstanding
61.98M 61.31M 44.99M 35.36M 25.35M
Weighted Average Shares Outstanding (Diluted)
61.98M 61.31M 44.99M 35.36M 25.35M
Currency in USD

Fulcrum Therapeutics Earnings and Revenue History